stella
beta
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers — Stella
Recruiting
Back to Urothelial Carcinoma trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
France
Oncopole Claudius Regaud, IUCT-O, Toulouse
View full record on ClinicalTrials.gov